|
⚲
|
| Portola Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001269021 |
| Sale | 2008-07-09 ($60.1 M Offered, $60.1 M Sold) |
| Fund | |
| Phone | 6502446864 |
| Address | 270 East Grand Avenue, Suite 22 South San Francisco, 94080 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Charles Homcy | |
| David Phillips | |
| Russell Hirsch | |
| Jeff Bird | |
| Pamela Green | |
| Jean George | |
| Alan Frazier | |
| Henry Wolff | |
| Farah Champsi | |
| Peggy Phillips | |
| Nicholas Galakatos | |
| Mardi Dier |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Gold Standard Mining Co
✚
|
0.0 | |
|
Goldstein David
✚
|
0.0 | |
|
Goldstein Howard
✚
|
0.0 | |
|
Goldstein Peter A
✚
|
0.0 | |
|
Chatterjee Fund Management LP
✚
|
0.0 | |
|
Chautauqua IIA, LLC
✚
|
0.0 | |
|
Chautauqua IIB, LLC
✚
|
0.0 | |
|
Openminded Fund I LP
✚
|
0.0 | |
|
CH CMR Partners LLC
✚
|
0.0 | |
|
Goldsmith Daniel Tucker
✚
|
0.0 |